In this study, we found that DCLK1 played a prominent role in maintaining CSC traits, promoting metastasis and reducing infiltration of CD8+ cells in tumor immune microenvironment with a concomitant resistance to chemotherapeutics and immune checkpoint inhibitors (ICIs) in TNBC. Here, DCLK1 is linked to neoplasm.